Christine Scheidig

Title: Christine Scheidig: Innovator in Malaria Research

Introduction

Christine Scheidig is a prominent inventor based in Savigny-Le-Temple, France. She has made significant contributions to the field of malaria research, particularly in understanding the mechanisms of Plasmodium falciparum, the parasite responsible for the most severe form of malaria.

Latest Patents

Christine holds a patent titled "Identification of the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) that mediates adhesion to chondroitin sulfate A." This invention relates to the discovery of a var gene and corresponding protein that modulates the adhesion of parasitized red blood cells to chondroitin sulfate A. The patent also discloses novel biological tools, prophylactics, therapeutics, diagnostics, and methods of use related to this discovery. She has 1 patent to her name.

Career Highlights

Christine is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work focuses on developing innovative solutions to combat malaria, which remains a significant global health challenge.

Collaborations

Christine has collaborated with notable researchers in her field, including Artur Scherf and Louis H. Miller. These collaborations have furthered the understanding of malaria and contributed to the development of potential treatments.

Conclusion

Christine Scheidig's work exemplifies the critical role of innovation in addressing global health issues such as malaria. Her contributions through her patent and collaborations highlight the importance of research in developing effective solutions.